## Abstract Die 2‐Chinoxalinone **4–6** und 2,3‐Chinoxalindione **16–18** warden nach der Silyl‐Methode unter Et~2~O‐BF~3~‐Katalyse ribosidiert und liefern hierbei die entsprechenden Nucleoside **10–12** bzw. **22–24**. Durch Schutzgruppenabspaltung lassen sich hieraus die freien Chinoxalinnucleosi
Nucleotide. IX. Synthese und Eigenschaften von 1-(2′-Desoxy-D-ribofuranosyl)-lumazin-3′-monophosphaten
✍ Scribed by Ramamurthy Charubala; Wolfgang Pfleiderer
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- German
- Weight
- 497 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0018-019X
No coin nor oath required. For personal study only.
✦ Synopsis
Nucleotides. IX. Synthesis and properties of 1‐(2′‐deoxy‐D‐ribofuranosyl)‐lumazin‐3′‐monophosphates
The synthesis of various 1‐(2′‐deoxy‐α‐[and β‐]D‐ribofuranosyl)‐lumazine‐3′‐monophosphates 25‐‐30 starting from the corresponding pteridine nucleosides 1‐‐6 is described. Monomethoxytritylation in 5′‐position to 7‐‐12, phosphorylation by cyanoethylphosphate to 13‐‐18, and deprotection by acid and base treatment afforded the lumazine nucleotides 25‐‐30 in good overall yield. The various reaction products have been characterized by physical means, such as UV. spectra, p__K__‐values and their chromatographical and electrophoretical behaviour. Enzymatic dephosphorylations by alkaline phosphatase led to the starting material 1‐‐6 with a 3‐‐4 times slower hydrolysis rate in comparison to Tp.
📜 SIMILAR VOLUMES
Base1 (8.IX.80) Nucleosides and Nucleotides. Part 16. The Behaviour of 1-(2'-Deoxy-~-D-ribofurauosyl-2(1H)pyrimidinone-5'-triphosphate, 1~2'-Deoxy-~-~-ribofuranosyI-2(lH)-pyridinone-5'-triphosphate and 4-Amino-I -(2'-deoxy-~-~-ribofuranosyl)-2(1H)-pyridinone-5'-triphosphate towards DNA Polymerase #
## Abstract 5‐(α‐D‐Glucopyranosyloxymethyl)uridin (**4a**), 5‐(α‐D‐Glucopyranosyloxymethyl)‐2′‐desoxyuridin (**6a**) sowie sein β‐Anomeres **5a** erhält man durch Reaktion der Aglykone **1** bzw. **2** mit 2,3,4,6‐Tetra‐__O__‐acetyl‐β‐D‐glucopyranose (**3**) in Gegenwart von Bortrifluorid‐ätherat u
Autor, an welchen Korrespondenz zu richten ist.